Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 3
2003 6
2004 5
2005 12
2006 17
2007 23
2008 19
2009 32
2010 27
2011 27
2012 29
2013 30
2014 34
2015 31
2016 40
2017 46
2018 35
2019 41
2020 47
2021 45
2022 28
2023 28
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

536 results

Results by year

Filters applied: . Clear all
Page 1
Chronic lymphocytic leukaemia.
Hallek M, Shanafelt TD, Eichhorst B. Hallek M, et al. Among authors: shanafelt td. Lancet. 2018 Apr 14;391(10129):1524-1537. doi: 10.1016/S0140-6736(18)30422-7. Epub 2018 Feb 21. Lancet. 2018. PMID: 29477250 Review.
Physician burnout: contributors, consequences and solutions.
West CP, Dyrbye LN, Shanafelt TD. West CP, et al. Among authors: shanafelt td. J Intern Med. 2018 Jun;283(6):516-529. doi: 10.1111/joim.12752. Epub 2018 Mar 24. J Intern Med. 2018. PMID: 29505159 Free article. Review.
Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia.
Shanafelt TD, Wang XV, Kay NE, Hanson CA, O'Brien S, Barrientos J, Jelinek DF, Braggio E, Leis JF, Zhang CC, Coutre SE, Barr PM, Cashen AF, Mato AR, Singh AK, Mullane MP, Little RF, Erba H, Stone RM, Litzow M, Tallman M. Shanafelt TD, et al. N Engl J Med. 2019 Aug 1;381(5):432-443. doi: 10.1056/NEJMoa1817073. N Engl J Med. 2019. PMID: 31365801 Free PMC article. Clinical Trial.
Supporting Peer Supporters.
Shanafelt T, Sandborg C. Shanafelt T, et al. Jt Comm J Qual Patient Saf. 2022 Sep;48(9):427-429. doi: 10.1016/j.jcjq.2022.05.001. Epub 2022 May 13. Jt Comm J Qual Patient Saf. 2022. PMID: 35842285 Free PMC article. No abstract available.
Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial.
Shanafelt TD, Wang XV, Hanson CA, Paietta EM, O'Brien S, Barrientos J, Jelinek DF, Braggio E, Leis JF, Zhang CC, Coutre SE, Barr PM, Cashen AF, Mato AR, Singh AK, Mullane MP, Little RF, Erba H, Stone RM, Litzow M, Tallman M, Kay NE. Shanafelt TD, et al. Blood. 2022 Jul 14;140(2):112-120. doi: 10.1182/blood.2021014960. Blood. 2022. PMID: 35427411 Free PMC article. Clinical Trial.
536 results